Researchers from Salt Lake City-based University of Utah Health found that, while direct patient-to-patient transmission is rare, “there is a lot more movement of C. diff between surfaces ...

The effectiveness of fecal microbiota transplantation in resolving diarrhea associated with C difficile infection is influenced by donor antibiotic use and stool consistency.

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...